Low- and standard-dose peginterferon alfa-2a for chronic hepatitis C, genotype 2 or 3: Efficacy, tolerability, viral kinetics and cytokine response
Y. Rotman, B. B. Borg, A. Soza, J. J. Feld, A. A. Modi, R. Loomba, G. Lutchman, E. Rivera, E. Doo, M. G. Ghany, T. Heller, A. U. Neumann, T. J. Liang, J. H. Hoofnagle
Research output: Contribution to journal › Article › peer-review
8Scopus
citations
Fingerprint
Dive into the research topics of 'Low- and standard-dose peginterferon alfa-2a for chronic hepatitis C, genotype 2 or 3: Efficacy, tolerability, viral kinetics and cytokine response'. Together they form a unique fingerprint.